Erudio Healtherudio.com
Drug
Entrectinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying entrectinib: CUPISCO. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| CUPISCO NCT03498521 · Hoffmann-La Roche | unfavourable cancer of unknown primary | Phase 2 | 358 | 62 | Deep | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NAUTIKA1 NCT04302025 · Genentech, Inc. DeepView → | biomarker-selected resectable stages IB-III NSCLC | Phase 2 | Deep | View | |||
| ROME NCT04591431 · Fondazione per la Medicina Personalizzata DeepView → | advanced solid tumors | Phase 2 | Deep | View | |||
| STARTRK-1 NCT02097810 · Hoffmann-La Roche DeepView → | NTRK/ROS1/ALK-positive advanced or metastatic solid tumors | Phase 1 | Deep | View | |||
| STARTRK-2 NCT02568267 · Hoffmann-La Roche DeepView → | Not given | Phase 2 | Deep | View | |||
| ROSALINE NCT04551495 · Jules Bordet Institute DeepView → | ER+ HER2-negative invasive lobular breast carcinoma | Phase 2 | Deep | View | |||
| BFAST NCT03178552 · Hoffmann-La Roche DeepView → | advanced or metastatic non-small cell lung cancer | Phase 2/Phase 3 | Deep | View | |||
| HORIZON 1 NCT05170204 · Hoffmann-La Roche StandardView → | unresectable stage III non-small cell lung cancer | Phase 3 | Standard | View | |||
| STARTRK-NG NCT02650401 · Hoffmann-La Roche FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||